127 related articles for article (PubMed ID: 35045512)
21. [A case of adenosquamous carcinoma at the esophagogastric junction, initially diagnosed as collision carcinoma].
Sasaki Y; Harada M; Kurosaki S; Shimada Y; Hayashi M; Kamiichi H; Kawamura N; Kajiyama Y; Yao T
Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):848-55. PubMed ID: 25947020
[TBL] [Abstract][Full Text] [Related]
22. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
23. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen LT; Satoh T; Ryu MH; Chao Y; Kato K; Chung HC; Chen JS; Muro K; Kang WK; Yeh KH; Yoshikawa T; Oh SC; Bai LY; Tamura T; Lee KW; Hamamoto Y; Kim JG; Chin K; Oh DY; Minashi K; Cho JY; Tsuda M; Sameshima H; Kang YK; Boku N
Gastric Cancer; 2020 May; 23(3):510-519. PubMed ID: 31863227
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Non-Resectable Advanced Gastric Cancer for Which Nivolumab Was Markedly Effective].
Hanaka J; Hashimoto S; Takahashi S; Okuda Y; Kanamura S; Hara A; Kyoku K; Akiyama K; Takahashi M; Goya T
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1165-1167. PubMed ID: 34521797
[TBL] [Abstract][Full Text] [Related]
25. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report.
Takami T; Yasuda K; Uozumi N; Musiake Y; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
J Med Case Rep; 2021 Dec; 15(1):604. PubMed ID: 34930435
[TBL] [Abstract][Full Text] [Related]
26. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report.
Komo T; Suzuki T; Tazawa H; Sada H; Morimoto H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Tashiro H
Int J Surg Case Rep; 2021 Jul; 84():106161. PubMed ID: 34237686
[TBL] [Abstract][Full Text] [Related]
27. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme.
Soni M; Kiff C; Carroll R; Stein D; Saragoussi D; Nassar A; Maisey N; Tyas D
Future Oncol; 2021 Aug; 17(24):3163-3174. PubMed ID: 34098737
[TBL] [Abstract][Full Text] [Related]
28. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
29. [A Case of Advanced Gastric Cancer in Which Tumor Relapse Was Observed after Discontinuation of Nivolumab Due to Complete Response, and for Which Re-Administration Was Initiated].
Nishida K; Yagi H; Mizumoto R; Haeno M; Mori S; Nomura M; Yasuyama A; Yoshikawa Y; Sueda T; Matsumura T; Koga C; Miyagaki H; Tei M; Tsujie M; Akamaru Y
Gan To Kagaku Ryoho; 2023 Mar; 50(3):343-345. PubMed ID: 36927904
[TBL] [Abstract][Full Text] [Related]
30. Successful R0 resection after chemotherapy, including nivolumab, for gastric cancer with liver metastases: three case reports.
Kawai J; Yasufuku I; Fukada M; Asai R; Sato Y; Tajima YJ; Saigo C; Kiyama S; Makiyama A; Tanaka Y; Okumura N; Murase K; Miyazaki T; Matsuhashi N
Surg Case Rep; 2024 Jun; 10(1):138. PubMed ID: 38837046
[TBL] [Abstract][Full Text] [Related]
31. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
[TBL] [Abstract][Full Text] [Related]
32. [Hyperprogressive Disease during Treatment with Nivolumab for Recurrence of Gastric Cancer].
Takeoka T; Okada K; Matsuno H; Konishi K; Ota H; Yokoyama S; Fukunaga M; Kobayashi K
Gan To Kagaku Ryoho; 2020 Jan; 47(1):165-167. PubMed ID: 32381893
[TBL] [Abstract][Full Text] [Related]
33. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519
[TBL] [Abstract][Full Text] [Related]
34. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
35. Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer.
Toyota S; Orita H; Fukuyama Y; Motoyoshi S; Kawanami S; Maeda S; Kuramitsu E; Ichimanda M; Nagamatsu S; Nagata S; Kai S; Korenaga D; Mori M
In Vivo; 2020; 34(2):583-585. PubMed ID: 32111756
[TBL] [Abstract][Full Text] [Related]
36. [A Case of Conversion Surgery after SOX plus Nivolumab for Unresectable Advanced Gastric Cancer].
Sato T; Kawaoka T; Xaolin Y; Matsukuma S; Tokunou K; Yamamoto S
Gan To Kagaku Ryoho; 2024 Jan; 51(1):75-77. PubMed ID: 38247097
[TBL] [Abstract][Full Text] [Related]
37. Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
Chau I; Le DT; Ott PA; Korytowsky B; Le H; Le TK; Zhang Y; Sanchez T; Maglinte GA; Laurie M; Abraham P; Patel D; Shangguan T
Gastric Cancer; 2020 Jan; 23(1):133-141. PubMed ID: 31549264
[TBL] [Abstract][Full Text] [Related]
38. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
39. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report.
Ishida N; Miyazu T; Tamura S; Suzuki S; Tani S; Yamade M; Iwaizumi M; Osawa S; Hamaya Y; Shinmura K; Sugimura H; Miura K; Furuta T; Sugimoto K
World J Gastroenterol; 2020 Dec; 26(45):7263-7271. PubMed ID: 33362382
[TBL] [Abstract][Full Text] [Related]
40. [Laparoscopic Local Resection for a Gastric GIST with Ulcer Locating Near to the Esophagogastric Junction - A Case Report].
Tanaka Y; Kosuga T; Komatsu S; Okamoto K; Shoda K; Arita T; Konishi H; Morimura R; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1308-1310. PubMed ID: 29394616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
